Brief: Novartis Experimental Drug For ALS Fails In Another Pipeline Hit- Bloomberg News
16/09/2026 16:09
BRIEF-Novartis Experimental Drug For ALS Fails In Another Pipeline Hit- Bloomberg News Sept 16 (Reuters) -
NOVARTIS EXPERIMENTAL DRUG FOR ALS FAILS IN ANOTHER PIPELINE HIT- BLOOMBERG NEWS
Source text: https://tinyurl.com/y3tw3jpd
Further company coverage: NOVN.S
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Novartis AG
See all newsNovartis AG expected to post earnings of $2.27 a share - Earnings Preview
AbbVie's skin disease drug reduces lesions in trial, company eyes weight-loss combination (updated)
AbbVie's skin disease drug reduces lesions in trial, company eyes weight-loss combination
Brief: Novartis Receives European Commission Approval For Cosentyx
Insight: How cheap Chinese antibiotics threaten Europe's last major penicillin plant